Analysts Set Orthofix Medical Inc. (NASDAQ:OFIX) Target Price at $14.75

Posted by Geri Gentry on Sep 23rd, 2026

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) has earned a consensus recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $14.75.

Several research analysts have recently weighed in on OFIX shares. Weiss Ratings upgraded shares of Orthofix Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, September 11th. Barrington Research lifted their price objective on Orthofix Medical from $15.00 to $17.00 and gave the company an “outperform” rating in a report on Monday, July 6th. Finally, Canaccord Genuity Group decreased their price objective on shares of Orthofix Medical from $18.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, August 10th.

View Our Latest Report on Orthofix Medical

Orthofix Medical Trading Up 0.3%

Shares of OFIX opened at $8.98 on Wednesday. The firm has a market capitalization of $365.76 million, a PE ratio of -5.83 and a beta of 0.64. Orthofix Medical has a 12-month low of $8.50 and a 12-month high of $16.99. The company has a quick ratio of 1.67, a current ratio of 2.84 and a debt-to-equity ratio of 0.55. The stock’s fifty day simple moving average is $10.24 and its 200-day simple moving average is $10.84.

Orthofix Medical (NASDAQ:OFIX – Get Free Report) last issued its earnings results on Wednesday, August 5th. The medical device company reported ($0.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.02. The company had revenue of $210.93 million for the quarter, compared to analyst estimates of $209.28 million. Orthofix Medical had a negative net margin of 7.41% and a negative return on equity of 14.05%. As a group, research analysts predict that Orthofix Medical will post -1.29 earnings per share for the current year.

Institutional Investors Weigh In On Orthofix Medical

Hedge funds have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC acquired a new stake in shares of Orthofix Medical during the second quarter valued at about $30,000. Moore Capital Management LP bought a new stake in Orthofix Medical during the second quarter worth $781,000. Empowered Funds LLC purchased a new stake in shares of Orthofix Medical during the second quarter valued at approximately $321,000. Public Employees Retirement System of Ohio purchased a new stake in shares of Orthofix Medical during the 2nd quarter worth approximately $348,000. Finally, Bank of America Corp DE bought a new stake in shares of Orthofix Medical in the second quarter valued at approximately $2,667,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

About Orthofix Medical

(Get Free Report)

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical device company focused on spine and orthopedic care. The company develops and markets products intended to help physicians treat spinal disorders, support bone healing, and address orthopedic injuries and conditions.

Its portfolio includes spinal fixation and motion-preservation systems, interbody implants, bone graft and other biologic products, bone growth stimulation devices, and solutions for limb reconstruction and deformity correction.